| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Rui Lu
|
|||||||
| GSE42463 |
Phf19 knockdown effect on F9 embryonal carcinoma cells
|
4 |
|
Rui Lu | Dec 20, 2012 | |||
| GSE71437 |
Effect of DNMT3A R882H mutation or WT on gene expression in hematopoietic stem/progenitor cells with NRAS G12D co-transduction (Microarray)
|
12 | Rui Lu | Jun 23, 2016 | ||||
| GSE71439 |
Expression profiling of murine leukemia stem cell (LSC) lines established ex vivo by coexpression of R882H-mutated DNMT3A and NRAS-G12D post treatment with Dot1l inhibitor (Microarray)
|
10 | Rui Lu | Jun 23, 2016 | ||||
| GSE71472 |
Effect of DNMT3A R882H mutation or WT expression on epigenetic landscapes of hematopoietic stem/progenitor cells with NRAS G12D co-transduction (ChIP-seq)
|
13 | Rui Lu | Jun 23, 2016 | ||||
| GSE71473 |
Effect of DNMT3A R882H mutation or WT expression on global DNA methylation patterns of hematopoietic stem/progenitor cells with NRAS G12D co-transduction (eRRBS)
|
3 | Rui Lu | Jun 23, 2016 | ||||
| GSE71474 |
Epigenomic profiling studies of murine leukemia stem cell (LSC) lines established ex vivo by coexpression of R882H-mutated DNMT3A and NRAS-G12D (ChIP-seq)
|
8 | Rui Lu | Jun 23, 2016 | ||||
| GSE71475 |
Epigenetic perturbations by Arg882-mutated DNMT3A potentiate aberrant stem cell gene expression program and acute leukemia development
|
46 | Rui Lu | Jun 23, 2016 | ||||
| GSE93727 |
Structural basis for DNMT3A-mediated de novo DNA methylation (HumanMethylation450 BeadChip)
|
35 | Rui Lu | Jan 01, 2018 | ||||
| GSE99390 |
Structural basis for DNMT3A-mediated de novo DNA methylation (eRRBS)
|
6 | Rui Lu | Jan 01, 2018 | ||||
| GSE99391 |
Structural basis for DNMT3A-mediated de novo DNA methylation
|
41 | Rui Lu | Jan 01, 2018 | ||||
| GSE130094 |
Evidence supporting a dominant negative mechanism for DNMT3A hotspot mutation-mediated leukemic cell transformation
|
35 | Rui Lu | Jun 12, 2019 | ||||
| GSE130634 |
Effect of BRD4 inhibition in leukemic stem cells (Microarray)
|
4 | Rui Lu | Jun 12, 2019 | ||||
| GSE165979 |
Transcription Factor MEF2D is Required for the Maintenance of MLL-rearranged Acute Myeloid Leukemia [ATAC-Seq]
|
4 | Rui Lu | Oct 02, 2021 | ||||
| GSE165980 |
Transcription Factor MEF2D is Required for the Maintenance of MLL-rearranged Acute Myeloid Leukemia [ChIP-Seq]
|
4 | Rui Lu | Oct 02, 2021 | ||||
| GSE165981 |
Transcription Factor MEF2D is Required for the Maintenance of MLL-rearranged Acute Myeloid Leukemia [RNA-Seq]
|
6 | Rui Lu | Oct 03, 2021 | ||||
| GSE165983 |
Transcription Factor MEF2D is Required for the Maintenance of MLL-rearranged Acute Myeloid Leukemia
|
14 | Rui Lu | Oct 02, 2021 |
